Finally, to examine whether miR-572-mediated suppression of SOCS1 and p21 in ovarian cancer is clinically relevant, seven freshly collected ovarian cancer samples and two normal ovarian tissues were obtained for further study. This evidence concerns the gene CDKN1A and ovarian cancer.